The suit seeking a jury trial to determine whether Pfizer is liable in Carter Albrecht’s death was prepared by Barrett Stetson and Thomas Moynihan. A quick read-through of the 36-page document gives me the impression that they did their homework on the science and marketing of the smoking-cessation drug Chantix. The fact that Pfizer has already changed its label to warn about serious neuropsychiatric side effects wouldn’t seem to bode well for the drug maker. But it’s easy to see the tack the defense would take if this ever went to trial: Albrecht was drunk the night he was shot while banging on his neighbor’s door, and the coroner couldn’t say that Albrecht even had Chantix in his system that night — because only Pfizer knows how to test for the drug.
Get the D Brief Newsletter
Dallas’ most important news stories of the week, delivered to your inbox each Sunday.
Related Articles
Local News
In a Friday Shakeup, 97.1 The Freak Changes Formats and Fires Radio Legend Mike Rhyner
Two reports indicate the demise of The Freak and it's free-flow talk format, and one of its most legendary voices confirmed he had been fired Friday.
Local News
Habitat For Humanity’s New CEO Is a Big Reason Why the Bond Included Housing Dollars
Ashley Brundage is leaving her longtime post at United Way to try and build more houses in more places. Let's hear how she's thinking about her new job.
By Matt Goodman
Sports News
Greg Bibb Pulls Back the Curtain on Dallas Wings Relocation From Arlington to Dallas
The Wings are set to receive $19 million in incentives over the next 15 years; additionally, Bibb expects the team to earn at least $1.5 million in additional ticket revenue per season thanks to the relocation.
By Ben Swanger